Efalizumab Rebound Response to a Sequential Therapy of Infliximab Followed by Efalizumab

Publisher： Karger

E-ISSN： 1421-9832|218|1|73-74

ISSN： 1018-8665

Source： Dermatology, Vol.218, Iss.1, 2008-10, pp. : 73-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Infliximab then Efalizumab, the ‘Hit and Run’ Approach Does Not Work

By  

Dermatology, Vol. 216, Iss. 2, 2008-01 ,pp. : 171-172

Karger

Access to resources Recommend Favorite

Exacerbation of Pityriasis Rubra Pilaris under Efalizumab Therapy

By  

Dermatology, Vol. 215, Iss. 1, 2007-06 ,pp. : 72-75

Karger

Access to resources Recommend Favorite

Cytomegalovirus Colitis in a Patient Treated with Efalizumab

By  

Dermatology, Vol. 218, Iss. 1, 2008-11 ,pp. : 84-85

Karger

Access to resources Recommend Favorite

Efficacy of Short-Term Cyclosporine Treatment to Control Psoriasis-Related Events during Efalizumab Therapy

By  

Dermatology, Vol. 218, Iss. 2, 2008-10 ,pp. : 146-150

Karger

Access to resources Recommend Favorite

Investigation of +405 and –460 Polymorphisms of Vascular Endothelial Growth Factor in Psoriasis and Short-Term Responsiveness to Efalizumab Therapy

By  

Dermatology, Vol. 217, Iss. 3, 2008-06 ,pp. : 201-202

Karger

Access to resources Recommend Favorite